Mefkure ERASLAN SAHİN, Ilknur Col MADENDAG

The effect of 17-alpha-hydroxyprogesterone caproate on 75 g oral glucose tolerance test results and the prevalence of gestational diabetes mellitus

AbstractAim: The goal of the present study was to investigate the effects of 17-alpha-hydroxyprogesterone caproate (17-OHPC) on oral glucose tolerance test (75 g OGTT) results and the prevalence of gestational diabetes mellitus (GDM).Material and Methods: : In the present case-control study, 1,472 pregnant women were enrolled. Of these pregnant women, 146 had used 17-OHPC for at least one month between 16–24 weeks of gestation and the remaining 1,326 were the healthy control group. Diagnostic criteria presented by International Association of Diabetes and Pregnancy Study Group were applied for diagnosis GDM.Results: Maternal demographic characteristics were similar between groups. The mean starvation serum glucose level was importantly greater in the study group at 81.7 ± 9.3mg/dL versus 79.6 ± 13.3mg/dL in the control group. Mean first hour serum glucose was 144.4 ± 30.4mg/dl in the study group and 130.8 ± 36.9mg/dl in the control group, importantly greater in the study group. Mean second hour serum glucose was importantly greater in the study group at 111.5 ± 26.1mg/dl versus 104.8 ± 31.4mg/dl in the control group. Additionally, there was no statistically significant difference between the groups for GDM prevalence.Conclusion: The present study showed that 17-OHPC was importantly related to greater starvation, first hour, and second hourserum glucose levels compared with the healthy group.

PDF

___

1. Guo T, Wang Y, Zhang H, et al. The association between ambient temperature and the risk of preterm birth in China.Sci Total Environ 2018;613-14:439-46.
2. Blencowe H, Cousens S, Chou D, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health 2013;10:2.
3. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760-5.
4. Wu P, Gulati M, Kwok CS, et al. Preterm Delivery and Future Risk of Maternal Cardiovascular Disease: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7.
5. Kim SA, Lee SM, Kim BJ, et al. The risk of neonatal respiratory morbidity according to the etiology of late preterm delivery. J Perinat Med 2017;45:129-34.
6. da Fonseca EB, Bittar RE, Carvalho MH, et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003;188:419-24.
7. O’Brien JM, Adair CD, Lewis DF, et al. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2007;30:687-96.
8. Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011;38:18-31.
9. Vivat V, Cohen-Tannoudji J, Revelli JP, et al. Progesterone transcriptionally regulates the beta 2-adrenergic receptor gene in pregnant rat myometrium. J Biol Chem 1992;267:7975-8.
10. Gaspar R, Ducza E, Mihalyi A, et al. Pregnancyinduced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: role of G-protein activation and progesterone. Reproduction 2005 ;130:113-22.
11. Gyamfi C, Horton AL, Momirova V, et al. The effect of 17-alpha hydroxyprogesteronecaproate on the risk of gestational diabetes in singleton or twin pregnancies. Am J Obstet Gynecol 2009;201:392.
12. Madendag Y, Sahin E, Madendag Col I, et al. The effect of hyperemesis gravidarum on the 75 g oral glucose tolerance test screening and gestational diabetes mellitus. J Matern Fetal Neonatal Med 2018 ;31:1989-92.
13. Kim C, Liu T, Valdez R, et al. Does frank diabetes in first-degree relatives of a pregnant woman affect the likelihood of her developing gestational diabetes mellitus or nongestational diabetes? Am J Obstet Gynecol 2009;201:576.
14. Hedderson MM, Williams MA, Holt VL, et al. Body mass index and weight gain prior to pregnancy and risk of gestational diabetes mellitus. Am J Obstet Gynecol 2008;198:409.
15. Marathe PH, Gao HX, Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017. Diabetes 2017;9:320-24.
16. Rebarber A, Istwan NB, Russo-Stieglitz K, et al. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 2007;30:2277-80.
17. Waters TP, Schultz BA, Mercer BM, et al. Effect of 17alphahydroxyprogesterone caproate on glucose intolerance in pregnancy. Obstet Gynecol 2009;114:45-9.
18. Egerman R, Ramsey R, Istwan N, et al. Maternal characteristics influencing the development of gestational diabetes in obese women receiving 17-alpha-hydroxyprogesterone caproate. J Obes 2014;2014:563243.
19. Rouholamin S, Zarean E, Sadeghi L. Evaluation the effect of 17-alpha hydroxyprogesteronecaproate on gestational diabetes mellitus in pregnant women at risk for preterm birth. Adv Biomed Res 2015;4:242.
20. Wolfe K, Dearmond C, How H, et al. The rates of abnormal glucose challenge tests and gestational diabetes in women receiving 17alphahydroxyprogesterone caproate. Am J Perinatol 2011 ;28:741-6.
21. Eke AC, Sheffield J, Graham EM. 17alphaHydroxyprogesterone Caproate and the Risk of Glucose Intolerance in Pregnancy: A Systematic Review and Meta-analysis. Obstet Gynecol 2019;133:468-75.
22. Gonzalez C, Alonso A, Alvarez N, et al. Role of 17beta-estradiol and/or progesterone on insulin sensitivity in the rat: implications during pregnancy. The J Endocrinology 2000;166:283-91.
23. Picard F, Wanatabe M, Schoonjans K, et al. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation. Proceedings of the National Academy of Sciences of the United States of America 2002;99:15644-8.
24. Xiang AH, Kawakubo M, Kjos SL, et al. Long-acting injectable progestin contraception and risk of type 2 diabetes in Latino women with prior gestational diabetes mellitus. Diabetes Care 2006;29:613-7.
25. Kahn HS, Curtis KM, Marchbanks PA. Effects of injectable or implantable progestin-only contraceptives on insulin-glucose metabolism and diabetes risk. Diabetes Care 2003;26:216-25.
26. Campbell SE, Febbraio MA. Effect of the ovarian hormones on GLUT4 expression and contractionstimulated glucose uptake.Am J Physiol Endocrinol Metab 2002;282:1139-46
27. Campbell SE, Febbraio MA. Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway of skeletal muscle.Am J Physiol Endocrinol Metab 2001;281:803-8.
28. Sugaya A, Sugiyama T, Yanase S, et al. Expression of glucose transporter 4 mRNA in adipose tissue and skeletal muscle of ovariectomized rats treated with sex steroid hormones. Life Sci 2000;66:641-8.
29. Sutter-Dub MT, Kaaya A, Sfaxi A, et al. Progesterone and synthetic steroids produce insulin resistance at the post-receptor level in adipocytes of female rats. Steroids 1988;52:583-608.